1. Home
  2. IMNM vs GOODN Comparison

IMNM vs GOODN Comparison

Compare IMNM & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • GOODN
  • Stock Information
  • Founded
  • IMNM 2006
  • GOODN N/A
  • Country
  • IMNM United States
  • GOODN United States
  • Employees
  • IMNM N/A
  • GOODN 72
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • GOODN Real Estate
  • Sector
  • IMNM Health Care
  • GOODN Real Estate
  • Exchange
  • IMNM Nasdaq
  • GOODN Nasdaq
  • Market Cap
  • IMNM 748.3M
  • GOODN N/A
  • IPO Year
  • IMNM 2020
  • GOODN N/A
  • Fundamental
  • Price
  • IMNM $8.46
  • GOODN $23.49
  • Analyst Decision
  • IMNM Strong Buy
  • GOODN
  • Analyst Count
  • IMNM 5
  • GOODN 0
  • Target Price
  • IMNM $26.40
  • GOODN N/A
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • GOODN N/A
  • Earning Date
  • IMNM 08-11-2025
  • GOODN N/A
  • Dividend Yield
  • IMNM N/A
  • GOODN N/A
  • EPS Growth
  • IMNM N/A
  • GOODN N/A
  • EPS
  • IMNM N/A
  • GOODN N/A
  • Revenue
  • IMNM $10,938,000.00
  • GOODN N/A
  • Revenue This Year
  • IMNM N/A
  • GOODN N/A
  • Revenue Next Year
  • IMNM $310.65
  • GOODN N/A
  • P/E Ratio
  • IMNM N/A
  • GOODN N/A
  • Revenue Growth
  • IMNM N/A
  • GOODN N/A
  • 52 Week Low
  • IMNM $5.15
  • GOODN N/A
  • 52 Week High
  • IMNM $16.81
  • GOODN N/A
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 55.56
  • GOODN 59.94
  • Support Level
  • IMNM $8.46
  • GOODN $23.10
  • Resistance Level
  • IMNM $9.32
  • GOODN $23.92
  • Average True Range (ATR)
  • IMNM 0.47
  • GOODN 0.24
  • MACD
  • IMNM -0.04
  • GOODN 0.03
  • Stochastic Oscillator
  • IMNM 55.94
  • GOODN 75.47

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About GOODN Gladstone Commercial Corporation

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: